Abstract:Abstract Krüppel-like factor 5 (KLF5) is an evolutionarily conserved zinc finger-containing transcription factor promoting breast cell proliferation, survival, and tumor growth through upregulating its target gene FGF-BP. The protein abundance of KLF5 has been shown to be strictly regulated at transcriptional and posttranslational levels. Our previous studies suggest that the KLF5 protein degradation is through the ubiquitin proteasome pathway. The WWP1 E3 ligase can target KLF5 for ubiquitin-mediated proteasomal degradation. In this study, we demonstrated the F-box protein FBW7 targets KLF5 for proteolysis and suppresses KLF5's functions in breast cancer. The SCFFBW7 (SKP1-Cullin1-F-box) E3 ligase complex has been shown to target several oncoproteins, including MYC and CyclinE, for proteolysis. FBW7 could be a tumor suppressor due to its frequent mutations in multiple cancers. Here, we first demonstrated that inactivation of endogenous FBW7 by gene knockout, knockdown, or mutation remarkably increases the endogenous KLF5 protein abundances through blocking its degradation in multiple cell lines. Second, we found that overexpression of FBW7 decreases the exogenous and endogenous KLF5 protein levels in HEK293T and SUM149PT cell lines. Functionally, overexpression of FBW7 in the endogenous FBW7 mutated SUM149PT cells decreases the FGF-BP gene expression and the DNA synthesis. Importantly, knockdown of endogenous Fbw7 increases the FGF-BP gene expression, cell proliferation, and survival through upregulating the KLF5 expression in breast cells. These findings suggest that the Fbw7 tumor suppressor inhibit breast cancer cell proliferation and survival at least partially through targeting KLF5 for ubiquitin-mediated degradation. This new regulatory mechanism of KLF5 degradation may result in useful diagnostic and therapeutic targets for breast cancer and other cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3155.

Regulation of APC Cdh1 E3 Ligase Activity by the Fbw7/cyclin E Signaling Axis Contributes to the Tumor Suppressor Function of Fbw7

The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

Emerging Roles of the FBW 7 Tumour Suppressor in Stem Cell Differentiation

The Characteristics and Roles of Β‐trcp1/2 in Carcinogenesis

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

The Fbw7 Tumor Suppressor Targets Klf5 For Ubiquitin-Mediated Degradation And Suppresses Breast Cell Proliferation

Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.

E3 Ubiquitin Ligase FBW7α Inhibits Cholangiocarcinoma Cell Proliferation by Downregulating C-Myc and Cyclin E.

Regulation mechanism of Fbxw7-related signaling pathways

The Fbw7 Tumor Suppressor Regulates Glycogen Synthase Kinase 3 Phosphorylation-Dependent C-Myc Protein Degradation

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

FBW7-mediated ubiquitination and degradation of KLF5.

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

Regulation mechanism of Fbxw7-related signaling pathways (Review).

SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.

Cdh1 Inhibits WWP2-mediated Ubiquitination of PTEN to Suppress Tumorigenesis in an APC-independent Manner

Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations

Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3

Ubiquitin ligases: cell-cycle control and cancer